1. Home
  2. INDP vs SNDL Comparison

INDP vs SNDL Comparison

Compare INDP & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$2.63

Market Cap

350.4M

Sector

Health Care

ML Signal

HOLD

Logo SNDL Inc.

SNDL

SNDL Inc.

HOLD

Current Price

$1.26

Market Cap

335.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
SNDL
Founded
2000
2006
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
350.4M
335.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
INDP
SNDL
Price
$2.63
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
73.1K
1.5M
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.19
Revenue Next Year
N/A
$3.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$1.24
52 Week High
$10.57
$2.89

Technical Indicators

Market Signals
Indicator
INDP
SNDL
Relative Strength Index (RSI) 48.83 31.76
Support Level $2.42 N/A
Resistance Level $3.08 $1.49
Average True Range (ATR) 0.22 0.04
MACD -0.01 -0.00
Stochastic Oscillator 54.55 15.79

Price Performance

Historical Comparison
INDP
SNDL

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: